BioCentury
ARTICLE | Product Development

Changing models and minds to improve access to addiction treatment

How companies are changing reimbursement, education to improve access to addiction meds

April 12, 2019 7:10 PM UTC

A lack of acknowledgment by key stakeholders in the healthcare system that medications can treat opioid abuse, along with a fragmented reimbursement system, means that effective treatments aren’t getting to the majority of patients who need them, exacerbating the opioid crisis.

Although the three classes of medications on the market for opioid use disorder all reduced relapse and improved patient outcomes in clinical and observational studies, only a small fraction of patients are given these therapies, according to a study published March 20 by the National Academies of Sciences, Engineering and Medicine. ...

BCIQ Company Profiles

Alkermes plc

Orexo AB